Facilitative interaction between angiotensin II and oxidised LDL in cultured human coronary artery endothelial cells

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 2, Issue SUPPL. 1, 2001, Pages

  Mehta, Jawahar L ^a,b   Li, Dayuan ^a  

^a CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Angiotensin II; Endothelial cells; Oxidised LDL; Receptors

Indexed keywords

EID: 0001916723     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.1177/14703203010020011201     Document Type: Article

References (36)

1. Witzum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991;88:23-8.
2. Schumacher M, Eber B, Tatzber F, Kaufmann P, Halwachs G, Fruhwald FM. Transient reduction of autoantibodies against oxidized LDL in patients with acute myocardial infarction. Free Rad Biol Med 1995;18:1087-91.
3. Harrison GJ, Jordan L, Selley M, Willis R. Low-density lipoproteins inhibit histamine and NaNO2 relaxations of the coronary vasculature and reduce contractile function in isolated rat hearts. Heart Vessels 1995;10:249-57.
4. Li DY, Yang BC, Mehta JL. Oxidized low density lipoprotein induces apoptosis in cultured human coronary artery endothelial cells: role of PKC, PTK, bcl-2, and Fas. Am J Physiol 1998;275:H568-H576.
5. Li DY, Mehta JL. Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells. Evidence from use of antisense LOX-1 mRNA and chemical inhibitors. Arterioscler Thromb Vasc Biol 2000;20:1116-22.
6. Li DY, Mehta JL. Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. Circulation 2000;101:2889-95.
7. Chen LY, Mehta P, Mehta JL. Oxidized LDL decreases L-arginine uptake and nitric oxide synthase protein expression in human platelets: Relevance of the effect of oxidized LDL on platlet function. Circulation 1996;93:1740-6.
8. Sawamura T, Kume N, Aoyama T et al. An endothelial receptor for oxidized low-density lipoprotein. Nature 1997;386:73-7.
9. Murase T, Kume N, Korenaga R et al. Fluid shear stress transcriptionally induces lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ Res 1998;83:328-33.
10. Kume N, Murase T, Moriwaki H et al. Inducible expression of lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ Res 1998;83:322-7.
11. Mehta JL, Li DY. Identification and autoregulation of receptor for ox-LDL in cultured human coronary artery endothelial cells. Biochem Biophys Res Commun 1998;248:511-4.
12. Kataoka H, Kume N, Miyamoto S et al. Expression of lectin-like oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation 1999;99:3110-7.
13. Feolde E, Vigne P, Frelin C. Angiotensin II receptor subtypes and biological responses in the rat heart. J Mol Cell Cardiol 1993;25:1359-67.
14. Yang BC, Phillips MI, Ambuehl PEJ, Sheen LP, Mehta P, Mehta JL. Increase in angiotensin II type 1 receptor expression immediately following ischemia-reperfusion in isolated rat hearts. Circulation 1997;96:922-6.
15. Timmermans PB, Smith RD. Angiotensin II receptor subtypes: selective antagonists and functional correlates. Eur Heart J 1994;15(Suppl D):79-87.
16. Yamada T, Horiuchi M, Dzau VJ. Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci USA 1996;93:156-60.
17. Li DY, Yang BC, Philips MI, Mehta JL. Pro-apoptotic effects of angiotensin II in human coronary artery endothelial cells: Role of AT1R receptor and PKC activation. Am J Physiol 1999;276:H786-H792.
18. Nickenig G, Bohm M. Regulation of the angiotensin AT1R receptor expression by hypercholesterolemia. Eur J Med Res 1997;2:285-9.
19. Keidar S, Kaplan M, Hoffman A and Aviram M. Angiotensin II stimulates macrophages-mediated oxidation of low density lipoproteins. Atherosclerosis 1995;115:201-15.
20. Keidar S, Attias J. Angiotensin II injection into mice increases the uptake of oxidized LDL by their macrophages via a proteoglycan-mediated pathway. Biochem Biophys Res Commun 1997;239:63-7.
21. 2+ modulation. Circ Res 1995;78:302-11.
22. Regitz-Zagrosek V, Friedel N, Heymann A et al. Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts. Circulation 1995;91:1461-71.
23. Regitz-Zagrosek V, Fielitz J, Dreysse R, Hildebrandt AG, Fleck E. Angiotensin receptor type 1 mRNA in human right ventricular endomyocardial biopsies: downregulation in heart failure. Cardiovasc Res 1997;35:99-105.
24. Harada K, Komuro I, Hayashi D, Sngaya T, Murakami K, Yazaki Y. Angiotensin II type 1a receptor is involved in the occurrence of reperfusion arrhythmias. Circulation 1998;97:315-7.
25. Dimmeler S, Rippmann V, Weiland U, Haendeler J, Zeiher AM. Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide. Circ Res 1997;81:970-6.
26. Nickenig G, Jung O, Strehlow K et al. Hypercholesterolemia is associated with enhanced angiotensin AT1-receptor expression. Am J Physiol 1997;272:H2701-H2707.
27. Yang BC, Phillips MI, Mohuczy D et al. Increased angiotensin II type 1 receptor expression in hypercholesterolemic atherosclerosis in rabbits. Arterioscler, Thromb and Vasc Biol 1998;18:1433-9.
28. Chen H, Li D, Sawamura T, Inoue K, Mehta JL. Upregulation of LOX-1 expression in aorta of hypercholesterolemic rabbits: modulation by losartan. Biochem Biophys Res Commun 2000;276:1100-4.
29. Bickel PE, Freeman MW. Rabbit aortic smooth muscle cells express inducible macrophage scavenger receptor messenger RNA that is absent from endothelial cells. J Clin Invest 1992;90:1450-7.
30. Kume N, Arai H, Kawai C, Kita T. Receptors for modified low density lipoproteins on human endothelial cells: different recognition for acetylated low-density lipoprotein and oxidized low-density lipoprotein. Biochim Biophys Acta 1991;1091:63-7.
31. Nagase M, Hirose S, Sawamura T, Tomoh M, Fujita T. Enhanced expression of endothelial oxidized low-density lipoprotein receptor (LOX-1) in hypertensive rats. Biochem Biophys Res Commun 1997;237:496-8.
32. Nickenig G, Sachinidis A, Michaelsen F, Bohm M, Seewald S, Vetter H. Upregulation of vascular angiotensin II receptor gene expression by low density lipoprotein in vascular smooth muscle cells. Circulation 1997;95:473-8.
33. Pitt B, Segal R, Martinez FA et al. Randomized trial of losartan versus captopril in patients over 65 with heart failure. Evaluation of losartan in the elderly study (ELITE). Lancet 1997;349:747-52.
34. Scandinavian Simvastatin Survival Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study. Lancet 1994;344:1383-5.
35. Berkenboom G, Langer I, Carpentier Y, Grosfils K, Fontaine J. Ramipril prevents endothelial dysfunction induced by oxidized low-density lipoproteins: a bradykinin-dependent mechanism. Hypertension 1997;30(3 Pt 1):371-6.
36. Rangaswamy S, Penn MS, Saidel GM, Chisolm GM. Exogenous oxidized low-density lipoprotein injures and alters the barrier function of endothelium in rats in vivo. Circ Res 1997;80:37-44.